Roche CEO warns of uncertainty over Brexit - Reuters

In an interview with Reuters, Roche (ROG: SIX) boss Severin Schwan has warned that the impact of Brexit - the UK’s exit from the European Union - remains a worrying uncertainty.

Dr Schwan said: “It goes without saying that we give preference in research and development activities where we bring the medicines to patients first.”

“Even though we very much appreciate the science and capabilities in the UK, it is not possible to disconnect that from access to innovative medicines.”